Han-Pei Hsu

Title: The Innovations of Han-Pei Hsu

Introduction

Han-Pei Hsu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of chemistry, particularly in the synthesis of heterocyclic compounds. With a total of two patents to his name, Hsu's work demonstrates a commitment to advancing pharmaceutical science.

Latest Patents

Hsu's latest patents include the "Stereoselective synthesis of intermediate for preparation of heterocyclic compound." This patent provides a method for synthesizing an intermediate that acts as a Cap-dependent endonuclease inhibitor. The process is characterized by its simple operation, higher yield, and controllable stereoselectivity, making it suitable for large-scale production. Another significant patent is "Trans-isomeric heterocyclic compounds and preparation thereof." This patent describes a trans-isomeric compound with a specific formula and a trans:cis ratio of at least 70:30, along with a method for its preparation.

Career Highlights

Throughout his career, Han-Pei Hsu has worked with various companies, including Taigen Biotechnology Company, Ltd. and Taigen Biopharmaceuticals Co. (Beijing), Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in biopharmaceuticals.

Collaborations

Hsu has collaborated with notable coworkers such as Wen-Chang Chen and Shan-Yen Chou. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Han-Pei Hsu's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the development of new therapeutic compounds.